Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

Market Cap	4.91B -30.8%
Revenue (ttm)	3.35B -2.2%
Net Income	337.40M -9.5%
EPS	2.20 -10.5%
Shares Out	153.40M
PE Ratio	14.57
Forward PE	n/a
Dividend	0.90 (2.84%)
Ex-Dividend Date	Apr 28, 2026

Volume	1,912,442
Average Volume	2,709,080
Open	31.79
Previous Close	31.72
Day's Range	31.52 - 32.16
52-Week Range	31.03 - 43.72
Beta	0.35
RSI	39.47
Earnings Date	Mar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1637
• Employees: 2,257
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600976

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.